Allal Boutajangout - Concepedia

Author

Allal Boutajangout

New York University

Also Known As

A Boutajangout, A. Boutajangout, Allal Boutajangout

Publications

Citations

H-Index

Concepts

All Affiliations

New York University Université Libre de Bruxelles New York State Office for People With Developmental Disabilities

About

Allal Boutajangout is an author at New York University specializing in medicine, alzheimer's disease, and neurodegenerative diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1K
2	Health Sciences	2	2	351
3	Social Sciences	2	2	344
4	Engineering	1	1	107
5	Allergy	1	1	304

Allal Boutajangout

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Passive immunization targeting pathological phospho‐tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain Allal Boutajangout, Johanna Ingadottir, Peter Davies, Journal of Neurochemistry Passive ImmunizationImmunologyCell DeathNeurochemical BiomarkersImmunotherapy	2011	304
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model Allal Boutajangout, David Quartermain, Einar M. Sigurdsson Journal of Neuroscience ImmunologyImmunodominanceNeurochemical BiomarkersImmune SystemImmunotherapy	2010	273
The active form of glycogen synthase kinase-3? is associated with granulovacuolar degeneration in neurons in Alzheimer's disease Allal Boutajangout, Karelle Leroy, M. Authelet, Acta Neuropathologica	2002	180
Induction of Toll-Like Receptor 9 Signaling as a Method for Ameliorating Alzheimer's Disease-Related Pathology Henrieta Scholtzova, Richard J. Kascsak, Kristyn A. Bates, Journal of Neuroscience	2009	165
Detection of Amyloid Plaques Targeted by Bifunctional USPIO in Alzheimer’s Disease Transgenic Mice Using Magnetic Resonance Microimaging Youssef Zaim Wadghiri, Jialin Li, Jinhuan Wang, PLoS ONE NanoparticlesEngineeringBifunctional UspioBiomedical EngineeringAlzheimer ’	2013	107
Vaccination of Alzheimer's model mice with Aβ derivative in alum adjuvant reduces Aβ burden without microhemorrhages Ayodeji A. Asuni, Allal Boutajangout, Henrieta Scholtzova, European Journal of Neuroscience	2006	92
Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1 Allal Boutajangout, Michèle Authelet, Véronique Blanchard, Neurobiology of Disease Knockout MouseNeurodegenerative DiseasesMolecular NeuroscienceAlzheimer's DiseaseTransgenic Mouse Models	2003	88
Expression of tau mRNA and soluble tau isoforms in affected and non‐affected brain areas in Alzheimer's disease Allal Boutajangout, Alain Boom, Karelle Leroy, FEBS Letters	2004	78
TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia Stephanie H. Greco, Lena Tomkötter, Anne-Kristin Vahle, PLoS ONE Chemoprevention StrategyImmunologyImmunotherapeuticsMetabolic RemodelingTumor Biology	2015	78
Blocking the apolipoprotein E/Amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology Shan Liu, Ariel Breitbart, Yanjie Sun, Journal of Neurochemistry Amyloid βTau PathologyImmunologyNeurochemical BiomarkersAmyloid Burden	2013	62

Page 1